Leukemia Clinical Trials in New York

Showing 261-280 of 1,542 trials

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

NCT06932081

This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.

Adult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more

Leiden University Medical Center400 participantsStarted Jan 2023

Baltimore, Maryland, United States • Grand Rapids, Michigan, United States • New York, New York, United States +8 more locations

COMPLETEDNA< 1 mile

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

NCT05900037

This is a pre-market, prospective, randomized (1:1), multicenter, pivotal clinical investigation. The purpose of this investigation is to determine the clinical performance of GATT-Patch as compared with SURGICEL® Original for the management of minimal, mild, or moderate bleeding during minimally invasive liver and gallbladder surgery.

Intraoperative BleedingLiver DiseasesGallbladder Diseases+1 more

GATT Technologies BV53 participantsStarted Oct 2023

Los Angeles, California, United States • St Louis, Missouri, United States • Pennington, New Jersey, United States +3 more locations

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Leukemia Trials in Other Cities

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

A Study of CTD402 in T-ALL/LBL Patients

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A Study of MGC026 in Participants With Advanced Solid Tumors

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)

FX Shoulder Prospective Clinical Study

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Other Conditions in New York